Clinicopathological prognostic factors commonly associated with increased risk of recurrence include large tumor size, nodal involvement, high tumor grade, negative hormone receptor status, HER2 overexpression, and the presence of lymph vascular invasion. Here, ERBB2 is linked to neoplasm.